In a report released today, Tim Anderson from Bank of America Securities reiterated a Sell rating on Amgen (AMGN – Research Report), with a ...
Driven by rapid innovations and the integration of modern technologies, the biotech sector is experiencing robust growth.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback